Why Reata Pharmaceuticals Nose-Dived on Monday

·2-min read
Why Reata Pharmaceuticals Nose-Dived on Monday

The FDA has raised concerns about one of the company's key pipeline candidates in advance of a crucial meeting.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting